Hydralazine 40mg Chewable Tablets
Chewable tablets with 40mg hydralazine, flavored for elderly patients with dysphagia in hypertension control. Dosage form for retail sale qualifies under HTS 3004.90.92.20 as measured cardiovascular medicament.
Import Duty Rates by Country of Origin
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Chewable tablets need tablet hardness and disintegration specs
• GRAS affirmation for all flavor/sweetener components
Related Products under HTS 3004.90.92.20
Hydralazine Hydrochloride 25mg Tablets
These are oral tablets containing 25mg of hydralazine hydrochloride, a vasodilator used to treat hypertension and heart failure. Classified under HTS 3004.90.92.20 as a cardiovascular medicament put up in measured doses for retail sale, consisting of unmixed active ingredient in tablet form.
Apresoline 25mg Scored Tablets (Hydralazine Brand)
Brand-name Apresoline tablets with 25mg hydralazine hydrochloride, scored for dose adjustment in hypertensive emergencies. Put up in retail packs, classified in HTS 3004.90.92.20 for specific hydralazine cardiovascular medicaments.
Generic Hydralazine 50mg Film-Coated Tablets
Film-coated generic tablets delivering 50mg hydralazine with improved swallowability for daily antihypertensive regimens. HTS 3004.90.92.20 covers this as dosage-form cardiovascular product containing hydralazine salts.
Pediatric Hydralazine 1mg/ml Suspension
Compounded oral suspension at 1mg/ml hydralazine for pediatric hypertensive patients, shaken before use. Put up in measured dose bottles for retail pharmacy, under HTS 3004.90.92.20 as therapeutic cardiovascular mixed product.
Hydralazine 20mg Transdermal Patch
24-hour transdermal patch system delivering 20mg hydralazine daily for compliant hypertension management. Specifically included in HTS 3004.90.92.20 description for transdermal administration systems of cardiovascular medicaments.
Hydralazine 50mg Extended-Release Tablets
Extended-release tablets providing 50mg hydralazine for once-daily dosing in managing chronic hypertension. Falls under HTS 3004.90.92.20 as a mixed product in measured doses for therapeutic cardiovascular use, put up for retail sale.